We are growing as a specialty pharmaceutical firm with a global presence by focusing on the development of new world-class drugs in selected therapeutic fields. In diagnostics, management resources are concentrated on products with strong growth prospects.
|Toshio Asano||President & Representative Director
Presidential Executive Officer
Primary Executive Officer
|Tadashi Nagatani||Executive Officer|
|Masayasu Shimadu||Executive Officer|
|Katsunori Horikoshi||Corporate Auditor|
|Seiji Nakano||Corporate Auditor|